CERS logo

Cerus (CERS) Company Overview

Profile

Full Name:

Cerus Corporation

Sector:

Healthcare

Country:

United States

IPO:

January 31, 1997

Indexes:

Not included

Description:

Cerus Corporation (CERS) focuses on developing and commercializing innovative blood safety products. Their main technology, INTERCEPT, helps inactivating pathogens in blood components, ensuring safer transfusions. Cerus aims to improve patient outcomes and enhance blood supply safety through advanced medical solutions.

Key Details

Price

$1.71

Annual Revenue

$156.37 M(-3.51% YoY)

Annual EPS

-$0.21(+12.50% YoY)

Annual ROE

-61.45%

Beta

1.84

Events Calendar

Earnings

Next earnings date:

Mar 5, 2025

Recent quarterly earnings:

Oct 30, 2024

Recent annual earnings:

Mar 5, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Oct 17, 24 Stifel
Buy
May 3, 24 Cantor Fitzgerald
Overweight
Apr 12, 24 Craig-Hallum
Buy
Mar 7, 24 Stephens & Co.
Equal-Weight
Mar 6, 24 Cantor Fitzgerald
Overweight
Jan 20, 23 BTIG
Neutral
May 27, 20 Stifel
Buy
Apr 16, 20 Stephens & Co.
Overweight
Feb 26, 20 BTIG Research
Buy
Feb 26, 20 BTIG
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript
Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript
Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript
CERS
seekingalpha.comOctober 30, 2024

Cerus Corporation (NASDAQ:CERS ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Jessica Hanover - VP, Corporate Affairs Obi Greenman - President & CEO Vivek Jayaraman - COO Kevin Green - CFO Conference Call Participants Matthew Park - Cantor Fitzgerald Colin Wells - Stifel Jacob Johnson - Stephens Joshua Jennings - TD Cowan Vidyun Bais - BTIG William Bonello - Craig-Hallum Capital Group Operator Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Cerus Corporation Third Quarter 2024 Earnings Conference Call.

Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates
Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates
Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates
CERS
zacks.comOctober 30, 2024

Cerus (CERS) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.03 per share a year ago.

Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024
Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024
Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024
CERS
businesswire.comOctober 18, 2024

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2024 financial results will be released on Wednesday, October 30, 2024, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit t.

Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates
Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates
Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates
CERS
zacks.comAugust 1, 2024

Cerus (CERS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.07 per share a year ago.

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
CERS
businesswire.comJune 21, 2024

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) today announced a lunch symposium and selection of abstracts at the 38th International Congress of the International Society of Blood Transfusion (ISBT), taking place in Barcelona, Spain, from June 23 through June 27. Transfusion medicine experts and professionals from around the world attend the ISBT Congress. The following is a list of selected presentations and abstracts of interest for Cerus. All presentation times are listed.

Cerus Corporation Celebrates World Blood Donor Day 2024
Cerus Corporation Celebrates World Blood Donor Day 2024
Cerus Corporation Celebrates World Blood Donor Day 2024
CERS
businesswire.comJune 14, 2024

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2024. In 2005, the World Health Assembly designated June 14 as World Blood Donor Day to recognize and thank blood donors across the world for their important contributions to the global blood supply. For 2024, the focus of this day is on all blood donors, essential for ensuring patients have access to blood transfusion, as well as on efforts to overcome challenges and.

Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript
Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript
Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript
CERS
Seeking AlphaMay 2, 2024

Cerus Corporation (NASDAQ:CERS) will be hosting a conference call to discuss their Q1 2024 results on May 2, 2024 at 4:30 PM ET. The call will feature key company executives including Jessica Hanover, Obi Greenman, Vivek Jayaraman, Kevin Green, and Carol Moore. Analysts participating in the call include Emily Christy, Jacob Johnson, Ross Osborne, and William Bonello. The operator will begin the call shortly. Thank you for joining us.

Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript
Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript
Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript
CERS
Seeking AlphaNovember 2, 2023

Cerus Corporation (NASDAQ:CERS ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Jessica Hanover - Vice President of Corporate Affairs Obi Greenman - President & Chief Executive Officer Vivek Jayaraman - Chief Operating Officer Kevin Green - Chief Financial Officer Conference Call Participants Operator Good day and thank you for standing by. Welcome to Cerus Corporation Second Quarter 2023 Earnings Conference Call.

Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates
Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates
Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates
CERS
Zacks Investment ResearchNovember 2, 2023

Cerus (CERS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.05 per share a year ago.

Cerus (CERS) Reports Q2 Loss, Lags Revenue Estimates
Cerus (CERS) Reports Q2 Loss, Lags Revenue Estimates
Cerus (CERS) Reports Q2 Loss, Lags Revenue Estimates
CERS
Zacks Investment ResearchAugust 2, 2023

Cerus (CERS) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.05 per share a year ago.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the ticker symbol for Cerus?
  • Does Cerus pay dividends?
  • What sector is Cerus in?
  • What industry is Cerus in?
  • What country is Cerus based in?
  • When did Cerus go public?
  • Is Cerus in the S&P 500?
  • Is Cerus in the NASDAQ 100?
  • Is Cerus in the Dow Jones?
  • When was Cerus's last earnings report?
  • When does Cerus report earnings?
  • Should I buy Cerus stock now?

What is the ticker symbol for Cerus?

The ticker symbol for Cerus is NASDAQ:CERS

Does Cerus pay dividends?

No, Cerus does not pay dividends

What sector is Cerus in?

Cerus is in the Healthcare sector

What industry is Cerus in?

Cerus is in the Medical Devices industry

What country is Cerus based in?

Cerus is headquartered in United States

When did Cerus go public?

Cerus's initial public offering (IPO) was on January 31, 1997

Is Cerus in the S&P 500?

No, Cerus is not included in the S&P 500 index

Is Cerus in the NASDAQ 100?

No, Cerus is not included in the NASDAQ 100 index

Is Cerus in the Dow Jones?

No, Cerus is not included in the Dow Jones index

When was Cerus's last earnings report?

Cerus's most recent earnings report was on Oct 30, 2024

When does Cerus report earnings?

The next expected earnings date for Cerus is Mar 5, 2025

Should I buy Cerus stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions